ABCAM LTD.

In News

Abcam Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Jul 28, 2026

Abcam joins LIGAND-AI project for AI drug discovery - Abcam

Abcam - Jan 20, 2026

Danaher to acquire Abcam for $24.00 per share - Abcam

Abcam - Mar 28, 2025

Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business - BioSpace

BioSpace - Nov 11, 2019

Abcam to Acquire BioVision for $340 million - GlobeNewswire

GlobeNewswire - Aug 02, 2021

Danaher to acquire Abcam in $5.7bn transaction - Financier Worldwide

Financier Worldwide - Oct 10, 2023

Danaher To Buy Life Sciences Co. Abcam In $5.7B Deal - law360.com

law360.com - Aug 28, 2023

PNO1 enhances ovarian cancer cell growth, invasion, and stemness via activating the AKT/Wnt/β-catenin pathway - Nature

Nature - Mar 20, 2025

Horseradish Peroxidase Market Size & Share – Trends Report, 2032 - gminsights.com

gminsights.com - May 31, 2024

How immunoassays accelerate throughput - Abcam

Abcam - Oct 09, 2024

ABCAM PLC: Final results for the year ended 31 December 2022 - PR Newswire

PR Newswire - Mar 20, 2023

Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition - Wiley & Sons

Wiley & Sons - Sep 18, 2019

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment